Associations of urinary levels of Kidney Injury Molecule 1 (KIM-1) and Neutrophil Gelatinase-Associated Lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA)

American Journal of Kidney Diseases

Volumn 60, Issue 6, 2012, Pages 904-911

  Peralta, Carmen A ^a,b   Katz, Ronit ^c   Bonventre, Joseph V ^d   Sabbisetti, Venkata ^d   Siscovick, David ^e   Sarnak, Mark ^f   Shlipak, Michael G ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^f TUFTS MEDICAL CENTER   (United States)

Author keywords

kidney function decline; Kidney injury molecule 1 (KIM 1); neutrophil gelatinase associated lipocalin (NGAL)

Indexed keywords

CREATININE; CYSTATIN C; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; KIDNEY INJURY MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

AGE; AGED; ALBUMINURIA; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENDER; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; RACE; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

ACUTE-PHASE PROTEINS; AGED; AGED, 80 AND OVER; ALBUMINURIA; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ETHNIC GROUPS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY DISEASES; LIPOCALINS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; RECEPTORS, VIRUS;

EID: 84868686759     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2012.05.014     Document Type: Article

References (35)

1. J. Coresh, E. Selvin, L.A. Stevens Prevalence of chronic kidney disease in the United States JAMA 298 2007 2038 2047
2. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 2004 1296 1305
3. C.S. Fox, M.G. Larson, E.P. Leip, B. Culleton, P.W. Wilson, D. Levy Predictors of new-onset kidney disease in a community-based population JAMA 291 2004 844 850
4. A. Guasch, W.M. Deen, B.D. Myers Charge selectivity of the glomerular filtration barrier in healthy and nephrotic humans J Clin Invest 92 1993 2274 2282
5. K. Mori, H.T. Lee, D. Rapoport Endocytic delivery of lipocalin- siderophore-iron complex rescues the kidney from ischemia-reperfusion injury J Clin Invest 115 2005 610 621
6. T.L. Nickolas, M.J. O'Rourke, J. Yang Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury Ann Intern Med 148 2008 810 819
7. T. Ichimura, J.V. Bonventre, V. Bailly Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury J Biol Chem 273 1998 4135 4142
8. W.K. Han, V. Bailly, R. Abichandani, R. Thadhani, J.V. Bonventre Kidney injury molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury Kidney Int 62 2002 237 244
9. W.K. Han, G. Wagener, Y. Zhu, S. Wang, H.T. Lee Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery Clin J Am Soc Nephrol 4 2009 873 882
10. K. Damman, D.J. Van Veldhuisen, G. Navis Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate Heart 96 2010 1297 1302
11. C.R. Parikh, P. Devarajan, M. Zappitelli Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery J Am Soc Nephrol 22 2011 1748 1757
12. G.S. Kuncio, E.G. Neilson, T. Haverty Mechanisms of tubulointerstitial fibrosis Kidney Int 39 1991 550 556
13. M. Zeisberg, E.G. Neilson Mechanisms of tubulointerstitial fibrosis J Am Soc Nephrol 21 2010 1819 1834
14. D. Bild, D.A. Bluemke, G. Burke Multi-Ethnic Study of Atherosclerosis: objectives and design Am J Epidemiol 156 2002 871 881
15. L.A. Inker, J. Eckfeldt, A.S. Levey Expressing the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) cystatin C equations for estimating GFR with standardized serum cystatin C values Am J Kidney Dis 58 2011 682 684
16. National Kidney Foundation KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease Am J Kidney Dis 49 suppl 2 2007 S12 S154
17. M.G. Shlipak, R. Katz, B. Kestenbaum Rapid decline of kidney function increases cardiovascular risk in the elderly J Am Soc Nephrol 20 2009 2625 2630
18. D.E. Rifkin, M.G. Shlipak, R. Katz Rapid kidney function decline and mortality risk in older adults Arch Intern Med 168 2008 2212 2218
19. C.A. Peralta, R. Katz, M.J. Sarnak Cystatin C identifies chronic kidney disease patients at higher risk for complications J Am Soc Nephrol 22 2011 147 155
20. C.A. Peralta, M.G. Shlipak, S. Judd Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality JAMA 305 2011 1545 1552
21. V.S. Vaidya, S.S. Waikar, M.A. Ferguson Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans Clin Transl Sci 1 2008 200 208
22. S. Shastri, R. Katz, M.G. Shlipak Cystatin C and albuminuria as risk factors for development of CKD stage 3: the Multi-Ethnic Study of Atherosclerosis (MESA) Am J Kidney Dis 57 2011 832 840
23. K.A. Nath Tubulointerstitial changes as a major determinant in the progression of renal damage Am J Kidney Dis 20 1992 1 17
24. B.C. Astor, A. Kottgen, S.J. Hwang, N. Bhavsar, C.S. Fox, J. Coresh Trefoil factor 3 predicts incident chronic kidney disease: a case-control study nested within the Atherosclerosis Risk in Communities (ARIC) Study Am J Nephrol 34 2011 291 297
25. C.M. O'Seaghdha, S.J. Hwang, N.A. Bhavsar Lower urinary connective tissue growth factor levels and incident CKD stage 3 in the general population Am J Kidney Dis 57 2011 841 849
26. J.V. Bonventre, L. Yang Kidney injury molecule-1 Curr Opin Crit Care 16 2010 556 561
27. A. Chiusolo, R. Defazio, E. Zanetti Kidney injury molecule-1 expression in rat proximal tubule after treatment with segment-specific nephrotoxicants: a tool for early screening of potential kidney toxicity Toxicol Pathol 38 2010 338 345
28. Y. Tonomura, N. Tsuchiya, M. Torii, T. Uehara Evaluation of the usefulness of urinary biomarkers for nephrotoxicity in rats Toxicology 273 2010 53 59
29. C.C. Szeto, B.C. Kwan, K.B. Lai Urinary expression of kidney injury markers in renal transplant recipients Clin J Am Soc Nephrol 5 2010 2329 2337
30. F. Waanders, V.S. Vaidya, H. van Goor Effect of renin-angiotensin- aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial Am J Kidney Dis 53 2009 16 25
31. F. Dieterle, F. Sistare, F. Goodsaid Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium Nat Biotechnol 28 2010 455 462
32. J. Mishra, C. Dent, R. Tarabishi Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery Lancet 365 2005 1231 1238
33. D. Bolignano, G. Coppolino, S. Campo Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease Am J Nephrol 27 2007 373 378
34. D. Bolignano, A. Lacquaniti, G. Coppolino Neutrophil gelatinase- associated lipocalin (NGAL) and progression of chronic kidney disease Clin J Am Soc Nephrol 4 2009 337 344
35. R.G. Fassett, S.K. Venuthurupalli, G.C. Gobe, J.S. Coombes, M.A. Cooper, W.E. Hoy Biomarkers in chronic kidney disease: a review Kidney Int 80 2011 806 821